Used in targeted cancer therapy, particularly for tumors with c-Met receptor overexpression or dysregulation. It inhibits hepatocyte growth factor (HGF)-mediated signaling, blocking pathways involved in tumor growth, invasion, and metastasis. Demonstrates therapeutic potential in cancers such as hepatocellular carcinoma, gastric cancer, and non-small cell lung cancer. Also serves as a research tool for studying c-Met pathway biology and for evaluating c-Met expression in diagnostic assays.